NCT02050802View on ClinicalTrials.gov

Study to Assess the Effect of Macitentan on the Electrocardiogram (ECG) in Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Healthy
Interventions
DRUG

Moxifloxacin 400 mg

DRUG

Macitentan 10 mg

DRUG

Macitentan 30 mg

OTHER

Placebo

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY

NCT02050802 - Study to Assess the Effect of Macitentan on the Electrocardiogram (ECG) in Healthy Male and Female Subjects | Biotech Hunter | Biotech Hunter